why choose us

First received: June 09, 2023

Clinical Trial: Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim

Study Status: Completed

Recruit Status: RECRUITING

Condition: Patient Preference

Study Type: OBSERVATIONAL


Official Title: Single-center, Randomized, Crossover Clinical Study to Assess Patient Preference Between the Use of a Prefilled Syringe or a Prefilled Pen Device for Pegfilgrastim Administration (PELGRAZ) as Primary

Brief Summary: Febrile neutropenia (NF) is a common serious complication of cancer chemotherapy.Outpatient management of chemotherapy treatments is made essential by the volume of patients treated, respect for their quality of life and the lack of hospitalization resources.The prevention of NF is well documented and its success depends on the risks of developing NF related to the type of chemotherapy protocol used and the profile of the patient and his disease.Pegfilgrastim (G-CSF, biosimilar medicine) injection has been shown…

Read more